These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24280017)
41. Ligand based NMR methods for drug discovery. Ludwig C; Guenther UL Front Biosci (Landmark Ed); 2009 Jan; 14(12):4565-74. PubMed ID: 19273371 [TBL] [Abstract][Full Text] [Related]
42. Mapping the bound conformation and protein interactions of microtubule destabilizing peptides by STD-NMR spectroscopy. Milton MJ; Thomas Williamson R; Koehn FE Bioorg Med Chem Lett; 2006 Aug; 16(16):4279-82. PubMed ID: 16765596 [TBL] [Abstract][Full Text] [Related]
43. Structure, epitope mapping, and docking simulation of a gibberellin mimic peptide as a peptidyl mimotope for a hydrophobic ligand. Murata T; Hemmi H; Nakamura S; Shimizu K; Suzuki Y; Yamaguchi I FEBS J; 2005 Oct; 272(19):4938-48. PubMed ID: 16176267 [TBL] [Abstract][Full Text] [Related]
44. The Nuclear Overhauser Effect in the lead identification process. Leone M; Freeze HH; Chan CS; Pellecchia M Curr Drug Discov Technol; 2006 Jun; 3(2):91-100. PubMed ID: 16925517 [TBL] [Abstract][Full Text] [Related]
45. Saturation transfer difference NMR spectroscopy as a technique to investigate protein-carbohydrate interactions in solution. Haselhorst T; Lamerz AC; Itzstein Mv Methods Mol Biol; 2009; 534():375-86. PubMed ID: 19277538 [TBL] [Abstract][Full Text] [Related]
46. [NMR screening in fragment-based drug discovery]. Hanzawa H; Takizawa T Yakugaku Zasshi; 2010 Mar; 130(3):325-33. PubMed ID: 20190517 [TBL] [Abstract][Full Text] [Related]
47. (15)N and (13)C group-selective techniques extend the scope of STD NMR detection of weak host-guest interactions and ligand screening. Kövér KE; Wéber E; Martinek TA; Monostori E; Batta G Chembiochem; 2010 Oct; 11(15):2182-7. PubMed ID: 20878964 [TBL] [Abstract][Full Text] [Related]
48. 1D NMR WaterLOGSY as an efficient method for fragment-based lead discovery. Raingeval C; Cala O; Brion B; Le Borgne M; Hubbard RE; Krimm I J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1218-1225. PubMed ID: 31286785 [TBL] [Abstract][Full Text] [Related]
49. Kinase drug discovery by affinity selection/mass spectrometry (ASMS): application to DNA damage checkpoint kinase Chk1. Comess KM; Trumbull JD; Park C; Chen Z; Judge RA; Voorbach MJ; Coen M; Gao L; Tang H; Kovar P; Cheng X; Schurdak ME; Zhang H; Sowin T; Burns DJ J Biomol Screen; 2006 Oct; 11(7):755-64. PubMed ID: 16956998 [TBL] [Abstract][Full Text] [Related]
50. Group epitope mapping considering relaxation of the ligand (GEM-CRL): including longitudinal relaxation rates in the analysis of saturation transfer difference (STD) experiments. Kemper S; Patel MK; Errey JC; Davis BG; Jones JA; Claridge TD J Magn Reson; 2010 Mar; 203(1):1-10. PubMed ID: 20022272 [TBL] [Abstract][Full Text] [Related]
51. Accounting for conformational variability in protein-ligand docking with NMR-guided rescoring. Skjærven L; Codutti L; Angelini A; Grimaldi M; Latek D; Monecke P; Dreyer MK; Carlomagno T J Am Chem Soc; 2013 Apr; 135(15):5819-27. PubMed ID: 23565800 [TBL] [Abstract][Full Text] [Related]
52. Identification of chemically diverse Chk1 inhibitors by receptor-based virtual screening. Foloppe N; Fisher LM; Howes R; Potter A; Robertson AG; Surgenor AE Bioorg Med Chem; 2006 Jul; 14(14):4792-802. PubMed ID: 16574416 [TBL] [Abstract][Full Text] [Related]
53. Epitope mapping by solution NMR spectroscopy. Bardelli M; Livoti E; Simonelli L; Pedotti M; Moraes A; Valente AP; Varani L J Mol Recognit; 2015 Jun; 28(6):393-400. PubMed ID: 25726811 [TBL] [Abstract][Full Text] [Related]
54. Synthesis and optimization of peptidomimetics as HIV entry inhibitors against the receptor protein CD4 using STD NMR and ligand docking. Neffe AT; Bilang M; Meyer B Org Biomol Chem; 2006 Sep; 4(17):3259-67. PubMed ID: 17036114 [TBL] [Abstract][Full Text] [Related]
55. Saturation transfer difference NMR spectroscopy for identifying ligand epitopes and binding specificities. Meyer B; Klein J; Mayer M; Meinecke R; Möller H; Neffe A; Schuster O; Wülfken J; Ding Y; Knaie O; Labbe J; Palcic MM; Hindsgaul O; Wagner B; Ernst B Ernst Schering Res Found Workshop; 2004; (44):149-67. PubMed ID: 14579779 [No Abstract] [Full Text] [Related]
56. Langerin-heparin interaction: two binding sites for small and large ligands as revealed by a combination of NMR spectroscopy and cross-linking mapping experiments. Muñoz-García JC; Chabrol E; Vivès RR; Thomas A; de Paz JL; Rojo J; Imberty A; Fieschi F; Nieto PM; Angulo J J Am Chem Soc; 2015 Apr; 137(12):4100-10. PubMed ID: 25747117 [TBL] [Abstract][Full Text] [Related]